Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Spyre Therapeutics (SYRE) Tax Rate (2021 - 2025)

Spyre Therapeutics' Tax Rate history spans 5 years, with the latest figure at 0.03% for Q1 2025.

  • For Q1 2025, Tax Rate rose 11.0% year-over-year to 0.03%; the TTM value through Dec 2025 reached 0.01%, up 3.0%, while the annual FY2025 figure was 0.01%, 3.0% up from the prior year.
  • Tax Rate reached 0.03% in Q1 2025 per SYRE's latest filing, up from 0.0% in the prior quarter.
  • In the past five years, Tax Rate ranged from a high of 1.13% in Q3 2022 to a low of 1.37% in Q2 2021.
  • Average Tax Rate over 5 years is 0.05%, with a median of 0.03% recorded in 2024.
  • Peak YoY movement for Tax Rate: skyrocketed 133bps in 2022, then crashed -114bps in 2023.
  • A 5-year view of Tax Rate shows it stood at 0.11% in 2021, then plummeted by -80bps to 0.2% in 2022, then skyrocketed by 96bps to 0.01% in 2023, then soared by 76bps to 0.0% in 2024, then skyrocketed by 1985bps to 0.03% in 2025.
  • Per Business Quant, the three most recent readings for SYRE's Tax Rate are 0.03% (Q1 2025), 0.0% (Q4 2024), and 0.03% (Q3 2024).